Clinical Trial Update: Vitamin D Supplementation for the Prevention of Cardiovascular Risk [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing whether vitamin D supplementation reduces cardiovascular risk in overweight and obese individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity
• Overweight

Drugs mentioned

• Vitamin D supplementation (Cholecalciferol)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Obesity, Overweight | Phase 4 | Status: COMPLETED